we report the 5-yr results of a prospective randomized study comparing 12 versus 6 cycles of cmf ( cyclophosphamide , methotrexate , fluorouracil ) with the aim to evaluate the possibility of reducing the duration of adjuvant treatment without compromising the therapeutic effect of the multimodal approach .
C0950521
cmf
C0010583
cyclophosphamide